Home > Analytics > PROCTER & GAMBLE HEALTH

PROCTER & GAMBLE HEALTH
Intrinsic Value | Fundamental Analysis

BOM : 500126     NSE : PGHL    
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Upward
Pledged Shares : None or < 25%
Jun 07,2023
Price(EOD): ₹ 5,183.05
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 8,603.86 Cr
Value of ₹ 1 Lac invested in PROCTER & GAMBLE HEALTH
on Jun 07,2018 (price: ₹ 2,343.20)

₹ 1 L

₹ 2.21 L

1W : -0.7% 1M : 11% 1Y : 21.5%
COMMUNITY POLL
for PROCTER & GAMBLE HEALTH
Please provide your vote to see the results
PROCTER & GAMBLE HEALTH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best 1M Momentum Small Cap Stocks
Industry Peers & Returns1W1M1Y
PROCTER & GAMBLE HEALTH -0.7% 11% 21.5%
SUN PHARMACEUTICAL INDUSTRIES 2.7% 5.9% 17.9%
DIVIS LABORATORIES 0.5% 4.8% 0.3%
CIPLA -0.4% 2.3% -1.5%
DR REDDYS LABORATORIES 2.6% -5.3% 7%
TORRENT PHARMACEUTICALS 1.5% 9.3% 27.1%
ABBOTT INDIA 1.3% -0.2% 18.8%
ZYDUS LIFESCIENCES 0.3% -1.9% 41.3%
ALKEM LABORATORIES 0.8% -5.8% 9.5%

FUNDAMENTAL ANALYSIS OF PROCTER & GAMBLE HEALTH

 
Fundamentals Score
[ Q(TTM): Mar2023, Y: Jun2022
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]

Insights 💡 PGHL is one of the top 35% companies with good fundamentals ! Discover More →

VALUATION OF PROCTER & GAMBLE HEALTH

 
Valuation Score
[As on : Jun 07,2023 ]

Ratio Standalone
P/E
P/B
P/S
35.72
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 240.84 Cr
[Latest Qtr - Mar2023 - Standalone Results ]

14.12
P/B Calculated based on Book Value of Rs 609.21 Cr
[Latest Year - Jun2022 - Standalone Results ]

7.03
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Mar2023 - Standalone Results ]

Financial Ratios →

Insights 💡 There are potential 23% undervalued companies ! Discover More →

FAIR VALUE OF PROCTER & GAMBLE HEALTH

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
69%
42%
37%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF PROCTER & GAMBLE HEALTH


Insights 💡 PGHL is one of the top 48% companies with bullish price momentum currently! Discover More →

PROCTER & GAMBLE HEALTH vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF PROCTER & GAMBLE HEALTH

Year Debt/Equity ratio
Standalone Consolidated
2022
2021
2020
Avg_3yrs
0
0
0
-
-
-
-
-
[Last Annual Data : Jun2022]
Financial Ratios →

PLEDGED PROMOTER SHARES OF PROCTER & GAMBLE HEALTH

Pledged Promoter Shares
0 %
As on : Mar2023

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF PROCTER & GAMBLE HEALTH

Standalone Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
3.53%
-27.83%
-25.17%
-22.93%
19.83%
15.84%
21.08%
15.7%
QtrlyTrend
2
Latest Qtr: Mar2023
Quarterly Result Analysis →


PROCTER & GAMBLE HEALTH related INDICES

BSE Indices1W1M1Y
S&P BSE SMALL CAP 3.3% 7.1% 18.8%
S&P BSE 250 SMALLCAP 3.2% 6.7% 20.4%
S&P BSE HEALTHCARE 3.2% 5.1% 10%
S&P BSE MIDSMALLCAP 2.9% 6.7% 19.4%
S&P BSE 400 MIDSMALLCAP 2.5% 6% 19.2%
No NSE index found

You may also like the below Video Courses


FAQ about PROCTER & GAMBLE HEALTH


Is PROCTER & GAMBLE HEALTH good for long term investment?

As on Jun 07,2023, the Fundamentals of PROCTER & GAMBLE HEALTH look Strong and hence it may be good for long term investment! See Financial Performance of PROCTER & GAMBLE HEALTH . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is PROCTER & GAMBLE HEALTH UnderValued or OverValued?

As on Jun 07,2023, PROCTER & GAMBLE HEALTH is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of PROCTER & GAMBLE HEALTH ?

As on Jun 07,2023, the Intrinsic Value of PROCTER & GAMBLE HEALTH is Rs. 3,649.35 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 3,062.20
Fair Value [Median EV / Sales Model] : Rs. 3,649.35
Fair Value [Median Price / Sales Model] : Rs. 3,790.24
Estimated Median Fair Value of PROCTER & GAMBLE HEALTH : Rs. 3,649.35

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is PROCTER & GAMBLE HEALTH trading at a Premium or Discount?

As on Jun 07,2023, PROCTER & GAMBLE HEALTH is trading at a Premium of 42% based on the estimates of Median Intrinsic Value!

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].